Bookmark and Share

BioActivity Data for Gene LYPLA1 (Gene ID:10434)

Also known as: APT-1, APT1, LPL-I, LPL1, hAPT1.
BioActivity Outcomes:
Probe(2)
 
 
Active(880)
 
 
Inactive(314877)
 
 
Unspecified(6)
 
 
BioAssay Types:
Screening(315580)
 
 
 
Confirmatory(21)
 
 
 
 
Literature(9)
 
 
Summary(2)
 
 
BioActivity Types:
IC50(10)
 
 
 
 
Ki(3)
 
 
 
Substance Types:
Chemical(315754)
 
 
 
 
 
RNAi(11)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 29    Data Row: 315765   Total Pages: 15789   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID99445332]
[CID71304779]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
2
[SID99445338]
[CID56593118]
Summary of probe development efforts to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2202, Type: summary] [gi:5453722]
View
3
[SID194168343]
[CID56641205]
IC50 0.0025Inhibition of APT1 (unknown origin) [AID1079563, Type: confirmatory] [gi:41017274]
View
4
[SID124968799]
[CID45100481]
IC50 0.0054Inhibition of APT1 (unknown origin) [AID1079563, Type: confirmatory] [gi:41017274]
View
5
[SID194134364]
[CID56593118]
IC50 0.017Inhibition of human APT1 [AID1079558, Type: confirmatory] [gi:41017274]
View
6
[SID194147576]
[CID11764509]
IC50 0.027Inhibition of APT1 (unknown origin) [AID1079563, Type: confirmatory] [gi:41017274]
View
7
[SID194175173]
[CID56593111]
IC50 0.03Inhibition of human APT1 [AID1079558, Type: confirmatory] [gi:41017274]
View
8
[SID164117611]
[CID71710938]
0.087Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in situ [AID743119_1, Type: confirmatory] [gi:5453722]
View
9
[SID164117614]
[CID71710927]
0.092Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
10
[SID164117611]
[CID71710938]
0.122Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
11
[SID194168344]
[CID11445232]
IC50 0.148Inhibition of APT1 (unknown origin) [AID1079563, Type: confirmatory] [gi:41017274]
View
12
[SID164117604]
[CID71710942]
0.154Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
13
[SID160654487]
[CID3238952]
0.21Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP [AID651990_1, Type: confirmatory] [gi:5453722]
View
14
[SID164117610]
[CID71710929]
0.225Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
15
[SID103711314]
[CID3238952]
Ki 0.3Inhibition of APT1 (unknown origin) by FluPol-ABPP assay [AID1079554, Type: confirmatory] [gi:41017274]
View
16
[SID164117613]
[CID71710939]
0.306Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_1, Type: confirmatory] [gi:5453722]
View
17
[SID194175172]
[CID16742753]
Ki 0.99Inhibition of APT1 (unknown origin) by enzyme kinetic assay [AID1079561, Type: confirmatory] [gi:41017274]
View
18
[SID17407908]
[CID3103481]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
19
[SID24811890]
[CID4291134]
Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] [gi:5453722]
View
20
[SID24811890]
[CID4291134]
Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of lysophospholipase 1 (LYPLA1). [AID2233, Type: screening] [gi:5453722]
View